Table 2.
Sample number | Tumor diagnosis | VHL status | CA12 expression* | CA9 expression* |
---|---|---|---|---|
1 | Meningioma | wt | — | 1 |
2 | Anaplastic astrocytoma | wt | — | — |
3 | Meningioma | wt | 1 | 2 |
4 | Meningioma | wt | 1 | 2 |
5 | Glioblastoma | wt | 4 | 10 |
6 | Glioblastoma | wt | — | — |
7 | Glioblastoma | wt | — | — |
8 | Astrocytoma | wt | 1 | 4 |
9 | Glioblastoma | wt | 2 | — |
10 | Cerebellar hemangioblastoma | wt | — | — |
11 | Meningioma | wt | 1 | — |
12 | Hemangioblastoma | mut | 2 | 2 |
13 | Cerebellar hemangioblastoma (VHL-) | mut | 6 | 4 |
14 | Cerebellar hemangioblastoma (VHL-) | mut | 6 | 3 |
15 | Spinal hemangioblastoma (VHL-) | mut | 2 | 1 |
16 | Spinal hemangioblastoma (VHL-) | mut | 3 | 4 |
17 | Cerebellar hemangioblastoma (VHL-) | mut | 5 | 4 |
18 | Hemangioblastoma (VHL-) | mut | 5 | 6 |
*Intensity of expression is shown in arbitrary units and based on β-actin calibration.